StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Oncotelic Therapeutics's pe ratio was 0.0× on Oct 19, 2026, against 5.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−0.6
2023Jul 31, 20230.7×−1.0
2022Dec 30, 20221.7×–

More Oncotelic Therapeutics figures

See a number that looks wrong?